Abstract
Infectious disease surveillance systems provide vital data for guiding disease prevention and control policies, yet the formalization of methods to optimize surveillance networks has largely been overlooked. Decisions surrounding surveillance design parameters—such as the number and placement of surveillance sites, target populations, and case definitions—are often determined by expert opinion or deference to operational considerations, without formal analysis of the influence of design parameters on surveillance objectives. Here we propose a simulation framework to guide evidence-based surveillance network design to better achieve specific surveillance goals with limited resources. We define evidence-based surveillance design as a constrained, multi-dimensional, multi-objective, dynamic optimization problem, acknowledging the many operational constraints under which surveillance systems operate, the many dimensions of surveillance system design, the multiple and competing goals of surveillance, and the complex and dynamic nature of disease systems. We describe an analytical framework for the identification of optimal designs through mathematical representations of disease and surveillance processes, definition of objective functions, and the approach to numerical optimization. We then apply the framework to the problem of selecting candidate sites to expand an existing surveillance network under alternative objectives of: (1) improving spatial prediction of disease prevalence at unmonitored sites; or (2) estimating the observed effect of a risk factor on disease. Results of this demonstration illustrate how optimal designs are sensitive to both surveillance goals and the underlying spatial pattern of the target disease. The findings affirm the value of designing surveillance systems through quantitative and adaptive analysis of network characteristics and performance. The framework can be applied to the design of surveillance systems tailored to setting-specific disease transmission dynamics and surveillance needs, and can yield improved understanding of tradeoffs between network architectures.
Author summary Disease surveillance systems are essential for understanding the epidemiology of infectious diseases and improving population health. A well-designed surveillance system can achieve a high level of fidelity in estimates of interest (e.g., disease trends, risk factors) within its operational constraints. Currently, design parameters that define surveillance systems (e.g., number and placement of the surveillance sites, target populations, case definitions) are selected largely by expert opinion and practical considerations. Such an informal approach is less tenable when multiple aspects of surveillance design—or multiple surveillance objectives— need to be considered simultaneously, and are subject to resource or logistical constraints. Here we propose a framework to optimize surveillance system design given a set of defined surveillance objectives and a dynamical model of the disease system under study. The framework provides a platform to conduct in silico surveillance system design, and allows the formulation of surveillance guidelines based on quantitative evidence, tailored to local realities and priorities. The approach facilitates greater collaboration between health planners and computational and data scientists to advance surveillance science and strengthen the architecture of surveillance networks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in part by National Institutes of Health grants nos. R01AI125842 and R01TW010286, and by the University of California Multicampus Research Programs and Initiatives award # 17-462 446315. We declare no competing interests.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† Denotes shared first authorship
Data Availability
Not applicable
